Source: Andelyn Biosciences By Kristin Heller, Plasmid Core Manager, and Andy Moreo, Head of Process Development, Plasmid and Viral Vector Core Facilities, Andelyn Biosciences GettyImages-517743436-plasmid-dna-development-lab The proliferation of targeted cell and gene therapies as first-line treatments for many rare and complex disease states has spurred... Learn More

Source: Andelyn Biosciences By Andy Moreo, Head of Process Development, Plasmid and Viral Vector Core Facilities, and Lenore Giannunzio, principal research scientist, Andelyn Biosciences Viral vectors are more than a vehicle for a payload – their ability to target... Learn More

https://fujifilmdiosynth.com/about-us/press-releases/fujifilm-diosynth-biotechnolgogies-breaks-ground-on-the-largest-cell-culture-biopharmaceutical-cdmo-facility-in-north-america/... Learn More

https://fujifilmdiosynth.com/about-us/press-releases/fujifilm-diosynth-biotechnologies-confirms-400-million-investment-plans-to-create-the-largest-multi-modal-biopharmaceutical-manufacturing-site-in-the-united-kingdom/... Learn More

https://fujifilmdiosynth.com/about-us/press-releases/fujifilm-diosynth-biotechnologies-to-increase-advanced-therapy-and-vaccine-production-capacity-with-new-300-million-facility-in-texas/... Learn More

https://fujifilmdiosynth.com/about-us/press-releases/fujifilm-expands-its-advanced-therapies-cdmo-business-with-the-acquisition-of-a-dedicated-cell-therapy-manufacturing-facility-from-atara-biotherapeutics-inc/... Learn More

https://fujifilmdiosynth.com/about-us/press-releases/fujifilm-completes-acquisition-of-a-dedicated-cell-therapy-manufacturing-facility-from-atara-biotherapeutics-inc/... Learn More

G-CON, the leader in off-site prefabricated, flexible cleanroom solutions, today launched its line of Viral Vector cleanroom infrastructure options, offering customers predesigned layouts to abbreviate design timelines and provide reliable budget and delivery timeframes. These processing space platforms have been designed based on G-CON’s deep experience in the space while... Learn More

G-CON, the leader in off-site prefabricated, flexible cleanroom solutions, today announced its capabilities to manufacture and deliver the company's signature standardPOD cleanrooms in Europe.  standardPODs, launched in the U.S. in 2020, are off-the-shelf cleanrooms designed to maximise efficiencies related to production, qualification, delivery and cost reduction and provide timeline certainty... Learn More

G-CON Manufacturing, Inc. has acquired Plasteurop, a leading France-based manufacturer of critical cleanroom components. Plasteurop’s core competence is the automated production of monolithic cleanroom wall panels and doors. These components are used in a variety of industries with stringent standards for cleanliness and quality. Plasteurop was founded in 1978 and... Learn More

Dear Current and Future Andelyn Partner,    We would like to invite you to join us at the ASGCT 25th Annual Meeting booth 148 this year in Washington D.C. The conference will be held from May 16th -May 19th at the Walter E. Washington Convention Center. We will... Learn More

Alt-R™ HDR Donor Blocks cater to market demand for better homology-directed repair research solutions CORALVILLE, Iowa — Global genomics solutions provider Integrated DNA Technologies (IDT) is empowering researchers to drive scientific discoveries in gene editing with the release of Alt-R HDR Donor Blocks, an improved solution for increasing... Learn More

VGXI opened the doors of its new headquarters and manufacturing facility on 09Apr22 to provide friends and employee families a first look inside and outside the new site! As production is nearing completion, the event was an opportunity for employees and their families to tour the... Learn More

Texas-based CDMO VGXI, Inc. is excited to announce that its partner, The Institute for Molecular Medicine, has recently been awarded a $12 million NIA grant to support clinical testing of a novel DNA vaccine manufactured by VGXI for the prevention of Alzheimer’s Disease. The Woodlands, TX –... Learn More

Global contract development and manufacturing organisation (CDMO), Recipharm, has today announced the acquisition of GenIbet, a Portuguese CDMO, specialising in the manufacture of biological clinical trial material and novel modalities such as viral vectors, RNA and microbiome. The acquisition forms part of Recipharm’s strategy to grow in... Learn More

Touchlight to break ground on world’s highest-capacity DNA manufacturing facility Touchlight, a biotechnology company pioneering enzymatic DNA production to enable the genetic medicine revolution, has received the first phase of planning approval for breaking ground on its new research and manufacturing facility in Hampton, UK. ... Learn More

SHANGHAI, March 22, 2022 /PRNewswire/ -- On March 22, 2022, OBiO Technology (Shanghai) Corp., Ltd. ("OBiO" or "the Company"), has completed its initial public offering ("IPO") process and started trading on the Shanghai Stock Exchange's Sci-Tech innovation board (SSE, code: 688238). Founded in 2013 and headquartered in Shanghai, OBiO... Learn More

Specialized GMP contract manufacturer VGXI, Inc. announced multiple construction milestones have been reached for its new headquarters and expanded manufacturing facility in Conroe, TX. The Woodlands, TX – VGXI, Inc., an industry-leading contract developer and manufacturer (CDMO) for nucleic acid biopharmaceuticals... Learn More